PJ Online | PJ Letters: Product names
The Pharmaceutical Journal
From Mr D. R. Kaye, MRPharmS
I note that the long-acting Lantus insulin has been launched in the United Kingdom (PJ, 10 August, p189). All pharmacists should be aware of the potential for confusion with insulin lente, especially with hand-written prescriptions.
The Institute for Safe Medication Practice has reported two cases of errors in the United States associated with Lantus and lente being confused.
Send your letter to The Editor
Citation: The Pharmaceutical Journal URI: 20007539